Inside Illumina’s bruising proxy battle with billionaire activist investor Carl Icahn

The idea that a simple blood test could detect early cancer in a healthy person has always seemed like a possibility that might one day benefit future generations. It’s not. Last year, the California-based biotech firm Grail released a $950 test called Galleri that can identify trace signs of more…

#grail #galleri #illumina #carlicahn #siliconvalleys #johnthompson #icahn #thompson #siliconvalley #jayflatley